Skip to content
OVistoaIntelligence index
AboutMethodologyPricingDocs
Sign inSign up
BREAKINGPerson found dead in car after it plows into health club in Portland, Oregon2 hr ago
Top StoriesUnited StatesCanadaWorldPoliticsGeneralBusinessTechHealthSportsAviationArtificial IntelligencePublishers

Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more

1 articles · 1 outlets · spread 0.00

Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more
FDA2 d ago

Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more

Full coverage view across outlets, lean, source quality, and framing. Compare framing without algorithmic ranking.

1 articles1 outletsSpread 0.0012 claims
OVistoa

Article-level news analysis, transparent scoring, and API tools for readers, publishers, and teams that need source context.

DMCA and copyright review

Copyright owners can submit notices, counter-notices, and source material concerns through the dedicated review flow.

Open DMCA review

Product

  • Home
  • Feed
  • Search
  • Topics
  • Saved

Platform

  • About
  • Methodology
  • Home
  • Search
  • Saved
  • Me

From the Left

0 outlets

No coverage from this perspective yet.

From the Center

1 outlet
  • STAT·May 1

    Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more

    By Ed SilvermanMay 1, 2026 Pharmalot Columnist, Senior Writer And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda: promenading with the official mascots, manicuring the Pharmalot grounds, and escorting Mrs. Pharmalot to a supper club. We also hope to find time for yet another listening party, where the rotation will likely include this, this, this, this, this. And what about you? As we like to remind folks, this is a fine time to enjoy the great outdoors. Hiking, strolling, dipping your toe in the water — take your pick. Of course, if the weather fails to cooperate, you could catch up on your reading, binge-watch on the telly, or tidy up around the castle. The possibilities are endless, yes? Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon…. The U.S. Food and Drug Administration proposed excluding the active ingredients in wildly popular obesity and diabetes drugs from a list of substances that can be used for making certain compounded versions, STAT writes. The agency determined there is no “clinical need”

From the Right

0 outlets

No coverage from this perspective yet.

Claim synthesis

Pro users see canonical claims across the cluster and which outlets reported each one.

Learn more

Outlets covering this story

STAT

First seen

May 1, 2026

Latest

May 1, 2026

Outlets

1

Diversity

100/100

  • Pricing
  • API docs
  • Publishers

    • Account

    • Sign in
    • Create account
    • Reader settings
    • API console

    Legal

    • Terms
    • Privacy
    • Security
    • DMCA

    © 2026 Vistoa. All rights reserved.

    Limited excerpts, attribution, analysis, and outbound publisher links remain core product boundaries.